Evidence map›Paper›PMID 37641484›Full record

Trial reportAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD.

Xin Wang, Erin E Sundermann, Rachel F Buckley, Sarah J Banks, A4 Study Team

Open access · hybridAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Usage and positivity rates of Alzheimer's disease biomarkers in a memory clinic.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Xin WangDepartment of Neurosciences, University of California, San Diego, California, USA.ORCID 0000-0003-0314-9268
Erin E SundermannDepartment of Psychiatry, University of California, San Diego, California, USA.
Rachel F BuckleyDepartment of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Sarah J BanksDepartment of Neurosciences, University of California, San Diego, California, USA.
A4 Study Team
University of California San Diego · USHarvard University · USPro Persona · NL

Funding

UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Mark W Bondi · 2019 to 2026
$34.9M
Sex-specific cognitive expression and risk in preclinical Alzheimer's diseaseR01AG066088 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BANKS, SARAH · 2019 to 2023
$3.9M
Sex Differences in the Clinical Expression of Alzheimer's Disease Neuropathology and Their Underlying Biological MechanismsR01AG074221 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUNDERMANN, ERIN ELIZABETH · 2021 to 2025
$2.7M
NIA NIH HHS P30 AG062429NIA NIH HHS R01 AG066088NIA NIH HHS R01 AG074221NIH HHS 1R01AG066088
6 · The paper itself

Abstract

introductionWe investigated how the associations between tau and cognitive measures differ by sex in the preclinical Alzheimer's disease (AD) stage.

methodsA total of 343 cognitively unimpaired, amyloid-positive individuals (205 women, 138 men) who self-identified as non-Hispanic White from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) Study were included. We assessed sex-stratified associations between

resultsWe observed that higher tau level was significantly associated with worse cognitive performance only in women: PACC and its components except for Mini-Mental State Examination (MMSE) and C3 components: First Letter Name Recall (FNLT) and One-Card Learning Reaction Time (OCL RT). These associations except for FNLT were apolipoprotein E (APOE) ε4 independent. DISCUSSION: Women show stronger associations between tau PET and cognitive outcomes in preclinical AD. These findings have important implications for sex-specific tau-targeted preventive AD clinical trials. HIGHLIGHTS: The tau positron emission tomography (PET) signal in the meta-temporal region was associated with poor cognitive performance in preclinical Alzheimer's disease (AD). After sex stratification, the associations between regional tau PET and cognitive outcomes were observed only in women. The associations between tau PET and some cognitive outcomes were independent of apolipoprotein E (APOE) ε4.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAmyloidAmyloid beta-PeptidesApolipoproteins EBrainCognitionFemaleHumansMalePositron-Emission TomographySex Characteristicstau ProteinsWhite PeopleAmyloidAmyloid beta-PeptidesApolipoproteins Etau ProteinsAlzheimer's diseaseAPOE ε4C3cognitionPACCsex differencestau PET

Identifiers

PMID37641484
PMCPMC10916995
OpenAlexW4386253564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.